1-6 of 6
Ceri E. Oldreive
Close
Sort by
Journal Articles

USP7 inhibition alters homologous recombination repair and targets CLL cells independently of ATM/p53 functional status

Angelo Agathanggelou, Edward Smith, Nicholas J. Davies, Marwan Kwok, Anastasia Zlatanou, Ceri E. Oldreive, Jingwen Mao, David Da Costa, Sina Yadollahi, Tracey Perry, Pamela Kearns, Anna Skowronska, Elliot Yates, Helen Parry, Peter Hillmen, Celine Reverdy, Remi Delansorne, Shankara Paneesha, Guy Pratt, Paul Moss, A. Malcolm R. Taylor, Grant S. Stewart, Tatjana Stankovic
Journal: Blood
Blood (2017) 130 (2): 156–166.
https://doi.org/10.1182/blood-2016-12-758219
Published: 2017
Includes: Supplemental data
Journal Articles

Primary CLL Xenograft: A Model System to Study the Role of T-Cells in CLL Biology and Therapeutic Response

Ceri E Oldreive, PhD, Anna Skowronska, PhD, Angelo Agathanggelou, PhD, Helen M Parry, Sergey Krysov, Graham K Packham, PhD, Rudzki Zbgniew, Guy Pratt, A. Malcolm R Taylor, PhD, Paul Moss, MDPhD, Tatjana Stankovic, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3284.
https://doi.org/10.1182/blood.V124.21.3284.3284
Published: 2014
Journal Articles

Targeted Treatments: Pre-Clinical Evaluation Of Efficacy By Tracking Clonal Diversity In CLL Xenograft Models

Nicholas J Davies, Ceri E Oldreive, PhD, Angelo Agathanggelou, Clive Gould, Guy Pratt, Mike Griffiths, Tatjana Stankovic, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 875.
https://doi.org/10.1182/blood.V122.21.875.875
Published: 2013
Journal Articles

Biallelic ATM Inactivation Significantly Reduces Survival in Chronic Lymphocytic Leukemia Patients Treated with Alkylating Agent/Purine Analogue Therapy: Results From the UKCLL4 Trial

Anna Skowronska, Gulshanara Ahmed, Ceri E Oldreive, PhD, David Oscier, MD, Anton Parker, Martin J.S. Dyer, MA, DPhil, Estella Matutes, MD, PhD, A. Malcolm R Taylor, PhD, Paul AH Moss, MD PhD, Tatjana Stankovic, MD PhD
Journal: Blood
Blood (2011) 118 (21): 467.
https://doi.org/10.1182/blood.V118.21.467.467
Published: 2011
Journal Articles

The PARP inhibitor olaparib induces significant killing of ATM -deficient lymphoid tumor cells in vitro and in vivo

Victoria J. Weston, Ceri E. Oldreive, Anna Skowronska, David G. Oscier, Guy Pratt, Martin J. S. Dyer, Graeme Smith, Judy E. Powell, Zbigniew Rudzki, Pamela Kearns, Paul A. H. Moss, A. Malcolm R. Taylor, Tatjana Stankovic
Journal: Blood
Blood (2010) 116 (22): 4578–4587.
https://doi.org/10.1182/blood-2010-01-265769
Published: 2010
Includes: Supplemental data
Journal Articles

CLL Xenograft Models to Address the Impact of Single Gene Loss (ATM) on Proliferation and Cytotoxic Response

Ceri E Oldreive, PhD, Victoria J Weston, PhD, Paul AH Moss, MD, PhD, Guy Pratt, Pamela R. Kearns, BSc, MBBCh, MRCP, PhD, A. Malcolm R Taylor, PhD, Tatjana Stankovic, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 2439.
https://doi.org/10.1182/blood.V116.21.2439.2439
Published: 2010